Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2023 Filed Dec 8, 2023 16:17 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Tax withholdingCommon Stock | 137.2232 | $149.40 | $20,501.15 |
DisclosureSEC source: 0001127602-23-029093 · form4.xml · nonDerivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,478.004 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:17 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Tax withholdingCommon Stock | 27.3324 | $149.40 | $4,083.46 |
DisclosureSEC source: 0001127602-23-029093 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,615.2272 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:17 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 27.3324 | $149.40 | $4,083.46 |
DisclosureSEC source: 0001127602-23-029093 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,642.5596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:19 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
Exercise / conversionRestricted Stock Units · Derivative | 78.9603 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029096 · form4.xml · derivative · entry 5 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712.0397 Underlying: Common Stock · 78.9603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:19 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
Tax withholdingCommon Stock | 78.9603 | $149.40 | $11,796.67 |
DisclosureSEC source: 0001127602-23-029096 · form4.xml · nonDerivative · entry 2 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,038.3978 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:19 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
Exercise / conversionCommon Stock | 78.9603 | $149.40 | $11,796.67 |
DisclosureSEC source: 0001127602-23-029096 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,117.3581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:21 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionRestricted Stock Units · Derivative | 32.3939 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029097 · form4.xml · derivative · entry 5 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414.6061 Underlying: Common Stock · 32.3939 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:21 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Tax withholdingCommon Stock | 32.3939 | $149.40 | $4,839.65 |
DisclosureSEC source: 0001127602-23-029097 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,815.0079 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:21 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionCommon Stock | 32.3939 | $149.40 | $4,839.65 |
DisclosureSEC source: 0001127602-23-029097 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,847.4018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,167 | $0.00 Strike: $98.55 | $0.00 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · derivative · entry 10 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 5,167 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,408 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · derivative · entry 9 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 1,408 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,167 | $153.47 | $792,979.49 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · nonDerivative · entry 4 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,620.166 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 5,167 | $98.55 | $509,207.85 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 10,787.166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,408 | $153.47 | $216,085.76 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,620.166 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 1,408 | $78.52 | $110,556.16 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 7,028.166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2023 Filed Dec 4, 2023 19:32 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 47.682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-028686 · form4.xml · derivative · entry 8 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 690.3275 Underlying: Common Stock · 47.682 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:41 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 8.5643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029083 · form4.xml · derivative · entry 5 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37.293 Underlying: Common Stock · 8.5643 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:44 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 38.4816 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029085 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470.7924 Underlying: Common Stock · 38.4816 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:46 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 198.3711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029086 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,297.6222 Underlying: Common Stock · 198.3711 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 176.7519 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · derivative · entry 7 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,305.8302 Underlying: Common Stock · 176.7519 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:51 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 27.0926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029088 · form4.xml · derivative · entry 8 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354.5356 Underlying: Common Stock · 27.0926 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:55 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantRestricted Stock Units · Derivative | 17.5915 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85.1794 Underlying: Common Stock · 17.5915 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 16:16 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14.4523 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029092 · form4.xml · derivative · entry 4 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60.4733 Underlying: Common Stock · 14.4523 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 16:17 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 2.4048 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029093 · form4.xml · derivative · entry 5 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.4048 Underlying: Common Stock · 2.4048 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 16:19 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 15.857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029096 · form4.xml · derivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85.1688 Underlying: Common Stock · 15.857 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 16:21 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 3.3699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029097 · form4.xml · derivative · entry 4 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.7811 Underlying: Common Stock · 3.3699 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2023 Filed Feb 22, 2024 21:16 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 42.1456 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006295 · form4.xml · derivative · entry 5 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730.5449 Underlying: Common Stock · 42.1456 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,661 | $0.00 Strike: $98.55 | $0.00 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · derivative · entry 8 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,661 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,122 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · derivative · entry 7 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 1,408 Underlying: Common Stock · 4,122 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 19,661 | $153.47 | $3,017,373.67 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · nonDerivative · entry 4 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,438.2241 Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 19,661 | $98.55 | $1,937,591.55 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,099.2241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 4,122 | $153.47 | $632,621.06 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,585.443 F1 · price: Weighted average price of the shares sold. The price range was $153.47 to $153.50. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 15:48 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 4,122 | $78.52 | $323,659.44 |
DisclosureSEC source: 0001127602-23-027498 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,707.443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 16:47 UTC |
Coombe Gary ACEO - Grooming
|
GiftCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-027329 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,737.8749 F1 · balance_after: Total includes shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,203 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · derivative · entry 7 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,203 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,095 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · derivative · entry 6 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,095 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 22,203 | $150.61 | $3,343,971.63 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · nonDerivative · entry 4 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,459.7906 F1 · price: Weighted average price of the shares sold. The price range was $150.50 to $150.84. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionCommon Stock | 22,203 | $80.29 | $1,782,678.87 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · nonDerivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,662.7906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 18,095 | $150.61 | $2,725,269.86 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,459.7906 F1 · price: Weighted average price of the shares sold. The price range was $150.50 to $150.84. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 17:29 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionCommon Stock | 18,095 | $85.13 | $1,540,427.35 |
DisclosureSEC source: 0001127602-23-026907 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,554.7906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 15:18 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,946 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-23-026349 · form4.xml · derivative · entry 5 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,946 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 15:18 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
SaleCommon Stock | 7,946 | $147.09 | $1,168,741.38 |
DisclosureSEC source: 0001127602-23-026349 · form4.xml · nonDerivative · entry 2 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,718.9787 F2 · price: Weighted average price of the shares sold. The price range was $147.1002 to $147.0800. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 15:18 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
Exercise / conversionCommon Stock | 7,946 | $78.66 | $625,032.36 |
DisclosureSEC source: 0001127602-23-026349 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,664.9787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 14:29 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 693 | $150.00 | $103,950.00 |
DisclosureSEC source: 0001127602-23-026221 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,742.1923 Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 14:31 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 412 | $150.00 | $61,800.00 |
DisclosureSEC source: 0001127602-23-026222 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,585.443 Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 14:31 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,868 | $150.00 | $280,200.00 |
DisclosureSEC source: 0001127602-23-026222 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,438.2241 Read SEC document |
| October 20, 2023 Filed Oct 23, 2023 14:39 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 188 | $148.52 | $27,921.76 |
DisclosureSEC source: 0001127602-23-026128 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 626.2947 Read SEC document |
| October 19, 2023 Filed Oct 23, 2023 14:37 UTC |
Jejurikar ShaileshChief Operating Officer
|
GiftCommon Stock | 1,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-026127 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Shailesh Jejurikar Trust Disclosed balance after: 5,026 Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:00 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025732 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,858.3598 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:02 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025733 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.